Harvard Bioscience reports Q4 revenue of $23.7M, outlines growth strategy Feb 10, 2026 07:31AM
Harvard Bioscience (HBIO) files for 9.5M share offering by selling stockholders Jan 30, 2026 05:04PM
Harvard Bioscience to close Massachusetts plant, move production to other sites Jan 29, 2026 04:30PM
Harvard Bioscience secures $40 million debt refinancing from BroadOak Dec 17, 2025 07:33AM
Harvard Bioscience (HBIO) Misses Q3 EPS by 4c Nov 6, 2025 07:26AM


Oct 3, 2025 08:05AM Harvard Bioscience gets 180-day extension to meet NASDAQ bid price rule
Sep 16, 2025 07:00AM Harvard Bioscience expands Fisher Scientific deal to US market
Sep 10, 2025 08:56AM Harvard Bioscience Inc. (HBIO) PT Lowered to $2 at Benchmark as Healthcare Faces 'Tough Year'
Jul 18, 2025 09:28AM Benchmark Reiterates Speculative Buy Rating on Harvard Bioscience Inc. (HBIO)
Jun 2, 2025 04:57PM Harvard Bioscience (HBIO) Appoints John Duke to Board of Directors
May 13, 2025 06:15AM Harvard Bioscience (HBIO) Reports In-Line Q1 EPS
Apr 14, 2025 10:25AM Benchmark Reiterates Speculative Buy Rating on Harvard Bioscience Inc. (HBIO)
Apr 10, 2025 04:45PM Harvard Bioscience (HBIO) Announces CFO Transition
Apr 9, 2025 02:10AM KeyBanc Downgrades Harvard Bioscience Inc. (HBIO) to Sector Weight
Mar 24, 2025 08:53AM Harvard Bioscience Inc. (HBIO) PT Lowered to $4.50 at Benchmark
Mar 12, 2025 07:25AM Harvard Bioscience (HBIO) Tops Q4 EPS by 1c
Dec 6, 2024 07:47AM Harvard Bioscience (HBIO) Files for $100M Mixed Shelf
Nov 7, 2024 08:14AM Harvard Bioscience (HBIO) Misses Q3 EPS by 4c
Aug 9, 2024 07:21AM Harvard Bioscience Inc. (HBIO) PT Lowered to $5.50 at Benchmark
Aug 8, 2024 03:09PM KeyBanc Reiterates Overweight Rating on Harvard Bioscience Inc. (HBIO)